| Title |
Severity-Adjusted Probability of Being Cost Effective
|
|---|---|
| Published in |
PharmacoEconomics, May 2019
|
| DOI | 10.1007/s40273-019-00810-8 |
| Pubmed ID | |
| Authors |
Matthijs M. Versteegh, Isaac Corro Ramos, Nasuh C. Buyukkaramikli, Amir Ansaripour, Vivian T. Reckers-Droog, Werner B. F. Brouwer |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 6 | 38% |
| United Kingdom | 2 | 13% |
| New Zealand | 1 | 6% |
| Greece | 1 | 6% |
| Germany | 1 | 6% |
| Unknown | 5 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 69% |
| Scientists | 3 | 19% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 80 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 14% |
| Researcher | 10 | 13% |
| Student > Bachelor | 7 | 9% |
| Student > Ph. D. Student | 5 | 6% |
| Student > Postgraduate | 2 | 3% |
| Other | 4 | 5% |
| Unknown | 41 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 9% |
| Economics, Econometrics and Finance | 7 | 9% |
| Decision Sciences | 3 | 4% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 5 | 6% |
| Unknown | 46 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#2,029,271
of 23,149,216 outputs
Outputs from PharmacoEconomics
#149
of 1,868 outputs
Outputs of similar age
#45,984
of 350,278 outputs
Outputs of similar age from PharmacoEconomics
#7
of 26 outputs
Altmetric has tracked 23,149,216 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,868 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,278 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.